Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578


News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 02:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.


- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at

Subscribe to WSJ:

Stocks mentioned in the article : SANOFI
React to this article
Latest news on SANOFI
11:11a SANOFI : Taking a Look Back at the 2014 Sanofi Season of Solidarity
07:31a SANOFI : MILITARY $26,231 Federal Contract Awarded to Sanofi Pasteur
07:09a GENZYME : Assigned Patent
06:04a SANOFI : Information concerning the total number of voting rights and shares
02:49a SANOFI : and Regeneron Release 18-Month Results of Odyssey Long Term Trial with ..
03/25 GENZYME : Studies from Genzyme Corporation Yield New Information about Neurodege..
03/25 SANOFI : Patent Issued for Inhaler for Powdery Substances, in Particular Medicin..
03/25 SANOFI : Pasteur : Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Chil..
03/25 SANOFI : Merial Assigned Patent
03/25 SANOFI : Chattem Assigned Patent
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes